Nusano's HALEU Platform Selected for NRIC Nuclear Energy Launch Pad USA Program
Nusano's HALEU Platform Selected for NRIC Nuclear Energy Launch Pad USA Program
PR Newswire
WEST VALLEY CITY, Utah, Sept. 14, 2026
Direct metallization process to produce 5.9 metric tons of nuclear fuel per unit per year
WEST VALLEY CITY, Utah, Sept. 14, 2026 /PRNewswire/ -- Nusano, a physics company pioneering advances in radioisotope and nuclear fuel production, has been selected by the National Reactor Innovation Center (NRIC) and the U.S. Department of Energy to develop its direct metallization HALEU nuclear fuel production line, as part of the Nuclear Energy Launch Pad Program, a federal initiative designed to accelerate innovative nuclear technologies from concept to commercial deployment.

Through Launch Pad, Nusano will gain access to DOE authorization processes, national laboratory expertise, infrastructure, technical resources, and project support intended to accelerate advanced nuclear technologies from development to deployment.
The Nusano HALEU production line uses metallic uranium feedstock instead of fluorinated uranium gas. The system is designed to produce HALEU in a single enrichment pass while reducing cost, enabling modular scalability, and eliminating hazardous fluorine chemistry. A Nusano HALEU unit requires just 1,200 square feet of operating space, allowing for additional units to be deployed incrementally as market demand grows. Nusano expects each unit will produce 5.9 metric tons (MT) of HALEU per year, with the first unit scheduled to be operational in 2031.
"Selection for Launch Pad signals Nusano's HALEU technology and team are ready to move forward," said Keith Titus, CEO of Nusano. "The review process considered each project's technical merit, operational readiness, and alignment with national strategic priorities. We're proud to be included and grateful for the opportunity to advance work to support America's energy independence."
Why HALEU Matters
HALEU, or high-assay low-enriched uranium, contains more uranium-235 than the fuel used in most reactors today while remaining below the threshold for highly enriched uranium. This makes HALEU useful for many small modular reactors, which can use it to produce more power from less fuel, run longer between refueling, and fit into smaller, more flexible designs.
Interest in SMRs is growing because they promise reliable, secure and affordable power in a more flexible and scalable format than traditional large nuclear plants. For many advanced designs, deployment depends on reliable access to HALEU fuel, making domestic fuel availability a critical factor in whether the market can scale.
The United States Department of Energy (DOE) estimates that domestic demand for HALEU could reach 50 MTU per year by 2035. Today, less than 1 MTU of HALEU is produced in the U.S. annually.
The Direct Metallization Difference
Currently, enriched uranium is primarily produced using gas centrifuges. This process spins uranium hexafluoride gas at high speed through connected centrifuges to increase the concentration of uranium-235.
Nusano's direct-metal feedstock pathway moves metallurgy earlier in the enrichment process and eliminates hazardous fluorine chemistry. The uranium feedstock is converted to metal before enrichment, then Nusano applies proprietary separation techniques to separate atoms by mass. For HALEU, the platform takes in uranium metal, enriches and separates uranium-235 from uranium-238, and outputs HALEU in metallic product form.
Benefits of direct metallization include:
- Simplicity – Eliminates the UF₆ conversion, deconversion, and metallization required in a gas centrifuge production process.
- Speed – Achieves full enrichment, from natural uranium to 19.75% enriched material, in a single-pass enrichment process.
- Efficiency – High feed-to-product ratio delivers high-volume HALEU production.
To learn more about Nusano's direct metallization HALEU platform, visit nusano.com/haleu.
About Nusano
Headquartered in West Valley City, Utah, Nusano is a privately held physics company working to stabilize supply chains, advance American national security by reducing dependency on foreign supply, and enable once-in-a-generation innovations in fields ranging from healthcare to nuclear energy. The company is commercializing platform technologies for radioisotope production, stable isotope enrichment, and advanced separation techniques. Together, these proprietary systems and methods are poised to supply the fight against cancer and help fuel America's nuclear renaissance. For more, visit nusano.com.
Contact:
Scott Larrivee, Nusano, (608) 345-6629, scott.larrivee@nusano.com

SOURCE Nusano
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
The 10 Best Companies to Invest in Now
2 Undervalued Stocks to Buy Before They Rebound
14 Elite Funds and ETFs, and 5 Popular Funds That Just Missed the Mark
